CBD, or cannabidiol, is a plant compound found in marijuana. It is one of over 113 cannabinoids found in cannabis, and makes up about 40% of the plant’s extract. It has many benefits, including pain relief, immune system support, and anti-inflammatory properties. In the form of hemp oil, CBD is a powerful compound that can treat a variety of ailments. Here are some common uses for CBD oil and its full form.
Cannabidiol
Cannabidiol is an orally available cannabinoid that is currently used to treat refractory epilepsy associated with Lennox-Gastaut and Dravet syndromes. However, cannabidiol is not approved for the treatment of multiple sclerosis, due to the inconsistent results of research. However, the FDA has given Epidiolex a conditional Notice of Compliance for treating neuropathic pain and spasticity in adults with multiple sclerosis. It has also been approved for treating seizures associated with tuberous sclerosis complex in patients one year of age and older.
Cannabidiol oil
Cannabidiol is an extract from the cannabis sativa plant and is most commonly known as CBD oil. It interacts with neuroreceptors in the endocannabinoid system, which sends messages between cells and regulates body functions such as mood, movement, and homeostasis. During the extraction process, solvents used vary from relatively harmless organic solvents to potentially harmful substances. In some cases, it is also extracted through a process called winterization, which removes other plant components from the final product.
Cannabidiol dosages
Cannabidiol doses vary widely, from six to four hundred milligrams per dose. The diversity of these doses highlights the importance of high-quality, large-scale clinical trials. For example, the drug Epidiolex, manufactured by GW Pharmaceuticals, has shown promising results in phase III studies in the United Kingdom. It has been used to treat epilepsy, seizures, and Dravet syndrome.
Cannabidiol uses
Cannabidiol in its full form is now available in medicine. The US Food and Drug Administration approved Epidiolex in 2018 for the treatment of multiple sclerosis, Dravet syndrome, and seizures associated with tuberous sclerosis complex. The drug has been approved for patients one year old and older. However, it remains unclear how effective it is for treating multiple sclerosis symptoms. It may have side effects and is not recommended for patients with severe or uncontrolled epilepsy.
Legality of CBD
The legal status of CBD in its full form is unclear. While its legality as a food supplement under the CSA appears to be expanding, the FD&C Act and state regulations remain undetermined. However, it is clear that the FDA is interested in protecting the public health by preventing the sale of unapproved CBD products. The FDA is partnering with local law enforcement to ensure that CBD products are safe and effective. Despite this, some companies still market CBD products that don’t meet FDA guidelines.
